Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia causes hair loss at the front hairline, and no effective treatment exists.

A rare family case of multiple benign hair follicle tumors was identified, highlighting the need to distinguish them from similar conditions.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

The document explains various skin conditions and their treatments.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

Hair transplant complications were likely due to deep graft placement and rough handling.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Doctors use their experience to choose treatments for scarring hair loss because it's hard to diagnose and treat.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

Syphilitic alopecia is a rare hair loss condition in secondary syphilis that looks similar to another condition but can be diagnosed with specific tests and responds to antibiotics.

The document concludes that corticosteroids effectively treat vasculitis allergica in over 90% of cases, with long-term kidney issues being the main adverse outcome.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Hair loss in black women needs more research, early intervention, and community education.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

A woman with hair loss had a benign sweat duct tumor found during a scalp biopsy.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.

The patient has a rare skin condition that shows features of two known disorders.

Lichen Planopilaris is a hair loss condition best treated early with various medications, including hydroxychloroquine, to prevent permanent baldness.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Trichofolliculoma, a rare benign hair follicle tumor, can potentially recur.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

Trichofolliculoma was found in a person with amniotic band syndrome for the first time.

Basaloid follicular hamartoma is a rare, benign skin growth often misdiagnosed.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.